(Bloomberg) — For all the recent backlash to drug price increases that have incited politicians' anger and roiled markets, a curious thing happened in the third quarter: Prices for generic drugs, which make up 85 percent of prescriptions, hardly increased at all.

That's according to an analysis from Bloomberg Intelligence analyst Jonathan Palmer, which shows inflation among generic drugs dropping from 4 percent two years ago to zero.

Prices of more expensive brand-name drugs have been increasing at more than 10 percent a year in that period.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.